We are live on !
Find out more
PM
Penbrook Management Portfolio holdings
AUM
$169M
Turnover
8.49%
1-Year Est. Return
32.52%
This Fund
S&P 500
This Quarter Est. Return
+11.23%
1 Year Est. Return
+32.52%
3 Year Est. Return
+106.62%
5 Year Est. Return
+155.24%
10 Year Est. Return
–
AUM
$149M
AUM Growth
+$12.4M
(+9.1%)
Cap. Flow
+$108K
Cap. Flow % of AUM
Cap. Flow %
0.07%
Top 10 Holdings %
Top 10 Hldgs %
53.42%
Holding
109
New
9
Increased
17
Reduced
49
Closed
5
Avg Time Held
Equity + Options
5.3
years
Top 10 Avg Time Held
Equity + Options
4.4
years
Top 20 Avg Time Held
Equity + Options
3.8
years
Avg Time Held Equity only
5.3
years
Top 10 Avg Time Held Equity only
4.4
years
Top 20 Avg Time Held Equity only
3.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Energy Transfer Partners
ET
|
+$985K |
| 2 |
NPK International
NPKI
|
+$606K |
| 3 |
Asure Software
ASUR
|
+$531K |
| 4 |
JPMorgan Equity Premium Income ETF
JEPI
|
+$267K |
| 5 |
Aehr Test Systems
AEHR
|
+$236K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CEQP
Crestwood Equity Partners LP
CEQP
|
+$1.01M |
| 2 |
Novo Nordisk
NVO
|
+$396K |
| 3 |
Microsoft
MSFT
|
+$295K |
| 4 |
John Wiley & Sons Class A
WLY
|
+$216K |
| 5 |
JPS
Nuveen Preferred & Income Securities Fund
JPS
|
+$210K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.9% |
| 2 | Technology | 24.13% |
| 3 | Energy | 12.64% |
| 4 | Financials | 11.01% |
| 5 | Industrials | 8.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
101
Antero Midstream
AM
$9.8B
| $125K | 0.08% |
10,000
| – | – |
2020 Q2
14 quarters
|
|
102
Eos Energy Enterprises
EOSE
$663M
| $13.6K | 0.01% |
12,500
| – | – |
2023 Q3
1 quarter
|
|
103
PUT
Photronics
PLAB
$1.62B
| $314 | ﹤0.01% |
+10,000
| New | +$222K |
2023 Q4
0 quarters
|
|
104
PUT
Axcelis
ACLS
$3.35B
| – | – |
-4,000
| Closed | -$652 | – |
|
105
DELISTED
Nuvve Holding Corp
NVVE
| – | – |
0
| – | -$22K |
2022 Q4
4 quarters
|
|
|
STKL
106
DELISTED
SunOpta
STKL
| – | – |
-60,065
| Closed | -$202K | – |
|
|
107
John Wiley & Sons Class A
WLY
$2.67B
| – | – |
-5,800
| Closed | -$216K | – |
|
|
CEQP
108
DELISTED
Crestwood Equity Partners LP
CEQP
| – | – |
-34,500
| Closed | -$1.01M | – |
|
|
JPS
109
DELISTED
Nuveen Preferred & Income Securities Fund
JPS
| – | – |
-34,000
| Closed | -$210K | – |
|
Similar funds
ACA
CCM
CIA
EG
ANHIM
WS
CBOR
NWMG
Penbrook Management's Q4 2023 Portfolio in Review
As of Q4 2023, Penbrook Management held 109 positions worth $149M, up 9.1% from $136M the previous quarter. Its ten largest holdings account for 53% of the portfolio.
Penbrook Management's Q4 2023 filing shows 9 new, 17 increased, 49 reduced and 5 closed positions. Its largest new stake was NPK International: 86,835 shares worth $577K. The largest sale was Crestwood Equity Partners LP, an estimated $1.01M.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 26% a quarter earlier, followed by Technology and Energy.
- Penbrook Management's largest Q4 2023 buy was NPK International: 86,835 shares worth $577K.
- Penbrook Management added most to Energy Transfer Partners in Q4 2023, an estimated $985K increase.
- Penbrook Management's biggest Q4 2023 reduction was Novo Nordisk, cutting an estimated $396K.
- Penbrook Management fully exited Crestwood Equity Partners LP in Q4 2023, selling an estimated $1.01M.
- Penbrook Management's ten largest holdings make up 53% of its $149M portfolio in Q4 2023.
- Penbrook Management opened 9 new positions and closed 5 in Q4 2023.
- Penbrook Management's portfolio value rose 9.1% quarter-over-quarter to $149M.
Based on Penbrook Management's 13F filing for Q4 2023, filed 16 Jan 2024.